IRWD FY 2024 Earnings — Ironwood Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

IRWDIronwood Pharmaceuticals, Inc.

$629M

FY 2024 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$351M-20.6% YoY

Gross Profit

$344M97.9% margin

Operating Income

$93M26.5% margin

Net Income

$880,0000.3% margin

EPS (Diluted)

$0.01

Cash Flow

Operating Cash Flow

$104M

Free Cash Flow

$103M

Stock-Based Comp.

$30M

Balance Sheet

Total Assets

$351M

Total Liabilities

$652M

Stockholders' Equity

-$301M

Cash & Equivalents

$89M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$351M	$443M	-20.6%
Gross Profit	$344M	$437M	-21.2%
Operating Income	$93M	-$945M	+109.8%
Net Income	$880,000	-$1.0B	+100.1%